1. Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt. 2005. 25:381–391.
2. Klein RM, Curtin BJ. Lacquer crack lesions in pathologic myopia. Am J Ophthalmol. 1975. 79:386–392.
3. Hotchkiss ML, Fine SL. Pathologic myopia and choroidal neovascularization. Am J Ophthalmol. 1981. 91:177–183.
4. Harris A, Bingaman DP, Ciulla TA, Martin BJ. Ryan SJ, Ogden TE, Hinton DR, editors. Retina and choroidal blood flow in health and disease. Retina. 2006. 4th ed. Philadelphia: Elsevier;83–102.
5. Chui TY, Yap MK, Chan HH, Thibos LN. Retinal stretching limits peripheral visual acuity in myopia. Vision Res. 2005. 45:593–605.
6. Atchison DA, Schmid KL, Pritchard N. Neural and optical limits to visual performance in myopia. Vision Res. 2006. 46:3707–3722.
7. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008. 146:496–500.
8. Grossniklaus HE, Green WR. Choroidal neovascularization. Am J Ophthalmol. 2004. 137:496–503.
9. Gomi F, Tano Y. Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol. 2008. 19:208–212.
10. Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina. 1996. 16:203–213.
11. Duke-Elder S, Abrams D. Pathological myopia. Duke-Elder's System of Ophthalmology, Refractive Optics and Refraction. 1970. v. 5. London: Henry Kimpton;308.
12. Kim KH, Kim DG. The relationship among refractive power, axial length and choroidal thickness measured by SD-OCT in Myopia. J Korean Ophthalmol Soc. 2012. 53:626–631.
13. Ikuno Y, Kawaguchi K, Nouchi T, Yasuno Y. Choroidal thickness in healthy Japanese subjects. Invest Ophthalmol Vis Sci. 2010. 51:2173–2176.
14. Margolis R, Spaide RF. A pilot study of enhanced depth imaging optical coherence tomography of the choroid in normal eyes. Am J Ophthalmol. 2009. 147:811–815.
15. Fujiwara T, Imamura Y, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009. 148:445–450.
16. Agawa T, Miura M, Ikuno Y, et al. Choroidal thickness measurement in healthy Japanese subjects by three-dimensional high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2011. 249:1485–1492.
17. Li XQ, Larsen M, Munch IC. Subfoveal choroidal thickness in relation to sex and axial length in 93 Danish university students. Invest Ophthalmol Vis Sci. 2011. 52:8438–8441.
18. Guyer DR, Schachat AP, Green WR. The choroid: structural considerations. Retina. 2006. 4th ed. Philadelphia: Elsevier;33–42.
19. Ikuno Y, Maruko I, Yasuno Y, et al. Reproducibility of retinal and choroidal thickness measurements in enhanced depth imaging and high-penetration optical coherence tomography. Invest Ophthalmol Vis Sci. 2011. 52:5536–5540.
20. Kim SW, Oh J, Kwon SS, et al. Comparison of choroidal thickness among patients with healthy eyes, early age-related maculopathy, neovascular age-related macular degeneration, central serous chorioretinopathy, and polypoidal choroidal vasculopathy. Retina. 2011. 31:1904–1911.
21. Ramrattan RS, van der Schaft TL, Mooy CM, et al. Morphometric analysis of Bruch's membrane, the choriocapillaris, and the choroid in aging. Invest Ophthalmol Vis Sci. 1994. 35:2857–2864.
22. Kiel JW, van Heuven WA. Ocular perfusion pressure and choroidal blood flow in the rabbit. Invest Ophthalmol Vis Sci. 1995. 36:579–585.
23. Lütjen-Drecoll E. Choroidal innervation in primate eyes. Exp Eye Res. 2006. 82:357–361.
24. Reitsamer HA, Zawinka C, Branka M. Dopaminergic vasodilation in the choroidal circulation by d1/d5 receptor activation. Invest Ophthalmol Vis Sci. 2004. 45:900–905.
25. Chou PI, Lu DW, Chen JT. Adrenergic supersensitivity of rabbit choroidal blood vessels after sympathetic denervation. Curr Eye Res. 2001. 23:352–356.
26. Shimura M, Uchida S, Suzuki A, et al. Reflex choroidal blood flow responses of the eyeball following somatic sensory stimulation in rats. Auton Neurosci. 2002. 97:35–41.
27. Delgado E, Marques-Neves C, Rocha I, et al. Intrinsic vasomotricity and adrenergic effects in a model of isolated rabbit eye. Acta Ophthalmol. 2009. 87:443–449.
28. Brown JS, Flitcroft DI, Ying GS, et al. In vivo human choroidal thickness measurements: evidence for diurnal fluctuations. Invest Ophthalmol Vis Sci. 2009. 50:5–12.
29. Archer D, Krill AE, Newell FW. Fluorescein studies of normal choroidal circulation. Am J Ophthalmol. 1970. 69:543–554.
30. Tanabe H, Ito Y, Iguchi Y, et al. Correlation between cross-sectional shape of choroidal veins and choroidal thickness. Jpn J Ophthalmol. 2011. 55:614–619.
31. Grossniklaus HE, Green WR. Pathologic findings in pathologic myopia. Retina. 1992. 12:127–133.
32. Okabe S, Matsuo N, Okamoto S, Kataoka H. Electron microscopic studies on retinochoroidal atrophy in the human eye. Acta Med Okayama. 1982. 36:11–21.
33. Hirata A, Negi A. Morphological changes of choriocapillaris in experimentally induced chick myopia. Graefes Arch Clin Exp Ophthalmol. 1998. 236:132–137.
34. Akyol N, Kükner AS, Ozdemir T, Esmerligil S. Choroidal and retinal blood flow changes in degenerative myopia. Can J Ophthalmol. 1996. 31:113–119.
35. To'mey KF, Faris BM, Jalkh AE, Nasr AM. Ocular pulse in high myopia: a study of 40 eyes. Ann Ophthalmol. 1981. 13:569–571.
36. Wakabayashi T, Ikuno Y. Choroidal filling delay in choroidal neovascularisation due to pathological myopia. Br J Ophthalmol. 2010. 94:611–615.
37. Ohno H. Electron microscopic studies of myopic retinochoroidal atrophies 1. Choroidal changes. Folia Ophthalmol Jpn. 1983. 43:1244–1253.
38. Vongphanit J, Mitchell P, Wang JJ. Prevalence and progression of myopic retinopathy in an older population. Ophthalmology. 2002. 109:704–711.
39. Kitzmann AS, Pulido JS, Diehl NN, et al. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980-2002. Ophthalmology. 2008. 115:169–173.
40. Wang Q, Klein BE, Klein R, Moss SE. Refractive status in the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 1994. 35:4344–4347.
41. Tsai MY, Lin LL, Lee V, et al. Estimation of heritability in myopic twin studies. Jpn J Ophthalmol. 2009. 53:615–622.
42. Sperduto RD, Seigel D, Roberts J, Rowland M. Prevalence of myopia in the United States. Arch Ophthalmol. 1983. 101:405–407.
43. Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration: results from the Blue Mountains Eye Study. Aust N Z J Ophthalmol. 1997. 25:Suppl 1. S13–S15.
44. Cho JH, Bae SH, Han JR, et al. Comparison of choroidal thickness in eyes with central serous chorioretinopathy, asymptomatic fellow eyes and normal eyes. J Korean Ophthalmol Soc. 2012. 53:87–93.
45. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology. 2010. 117:1792–1799.
46. Pryds A, Larsen M. Choroidal thickness following extrafoveal photodynamic treatment with verteporfin in patients with central serous chorioretinopathy. Acta Ophthalmol. 2011. 05. 17. doi:
10.1111/j.1755-3768.2011.02157.x. [Epub ahead of print].
47. Dirani M, Chamberlain M, Shekar SN, et al. Heritability of refractive error and ocular biometrics: the Genes in Myopia (GEM) twin study. Invest Ophthalmol Vis Sci. 2006. 47:4756–4761.
48. Munaut C, Lambert V, Noël A, et al. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol. 2001. 85:877–882.
49. Kavroulaki D, Gugleta K, Kochkorov A, et al. Influence of gender and menopausal status on peripheral and choroidal circulation. Acta Ophthalmol. 2010. 88:850–853.
50. Centofanti M, Bonini S, Manni G, et al. Do sex and hormonal status influence choroidal circulation? Br J Ophthalmol. 2000. 84:786–787.